Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
Sponsor: Sanofi
Summary
This is a multicentre, non-interventional, single arm study that aims to describe the treatment patterns in France: patients' characteristics, disease characteristics, prior treatments for Severe chronic rhinosinusitis with nasal polyposis and treatment prescription modalities. As well as to assess the clinical outcome after initiation of dupilumab (Dupixent®) and safety of the product during the two years of treatment
Official title: Observational Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Treated With Dupilumab in France
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2023-10-20
Completion Date
2026-07-31
Last Updated
2025-12-23
Healthy Volunteers
No
Interventions
Dupilumab
This study will not administer any treatment, only observe the treatment as prescribed in real world-clinical practice.
Locations (1)
Investigational Site Number: 250.0001
Nantes, France